Immunohistochemical investigation of thymidylate synthase in cervical cancer

Oncology

Volumn 55, Issue 6, 1998, Pages 564-568

  Suzuki, Mitsuaki ^a   Okabe, Hiroyuki ^b   Tsukagoshi, Shizuka ^a   Kawai, Toshiro ^a   Fukushima, Masakazu ^b   Sato, Ikuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Cervical cancer; FdUMP TS binding assay; Immunohistochemistry; Polyclonal antibody; Thymidylate synthase

Indexed keywords

FLOXURIDINE PHOSPHATE; PEROXIDASE; POLYCLONAL ANTIBODY; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME BINDING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADULT; AGED; ANTIBODIES; CYTOPLASM; FEMALE; FLUORODEOXYURIDYLATE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; THYMIDYLATE SYNTHASE; UTERINE CERVICAL NEOPLASMS;

EID: 0031726947     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011913     Document Type: Article

References (16)

1. Hashimoto Y, Shiotani T, Eble JN, Glover JL, Weber G: Increased thymidylate synthase (EC 2.1.1.45) activity in normal and neoplastic proliferation. Cancer Biochem Biophys 1988;10: 1-10.
2. Houghton JA, Weiss KD, Williams LG, Torrance PM, Houghton PJ: Relationship between 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration in xenografts of human colon adenocarcinomas. Biochem Pharmacol 1986;35:1351-1358.
3. Suzuki M, Ohwada M, Tamada T, Tsuru S: Thymidylate synthase activity as a prognostic factor in ovarian cancer. Oncology 1994;51: 334-338.
4. Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, Chabner BA, Allegra CJ: The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 1994;12:2640-2647.
5. Peters GJ, van der Wilt CL, van Groeningen CJ, Smid K, Meijer S, Pinedo HM: Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: Implications for treatment with fluorouracil. J Clin Oncol 1994;12:2035-2042.
6. Johnston PG, Lenz H-J, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV, Leichman L: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 1995;55:1407-1412.
7. Peters GJ, van der Wilt CL, van Triest B, Codacci-Pisanelli G, Johnston PG, van Groeningen CJ, Pinedo HM: Thymidylate synthase and drug resistance. Eur J Cancer 1995;31A: 1299-1305.
8. Leichman L, Lenz H-J, Leichman CG, Groshen S, Danenberg K, Baranda J, Spears CP, Boswell W, Silberman H, Onega A, Stain S, Beart R, Danenberg P: Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trial. Eur J Cancer 1995;31A:1306-1310.
9. Lenz H-J, Leichman CG, Danenberg KD, Danenberg PV, Groshen S, Cohen H, Laine L, Crookes P, Silberman H, Baranda J, Garcia Y, Li J, Leichman L: Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overall survival. J Clin Oncol 1995;14: 176-182.
10. Johnston PG, Liang C-M, Henry S, Chabner BA, Allegra CJ: Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res 1991;51: 6668-6676.
11. Jastreboff MM, Todd MB, Malech HL, Bertino JR: Isolation and functional effects of monoclonal antibodies binding to thymidylate synthase. Biochemistry 1985;24:587-592.
12. Aherne GW, Hardcastle A, Newton R: Measurement of human thymidylate synthase (hTS) in cell lines using ELISA. Ann Oncol 1992;3(suppl 1):77.
13. Okabe H, Tsujimoto H, Fukushima M: Preparation of the antibodies against recombinant human thymidylate synthase for the detection of its intratumoral levels and the application to sensitivity study of 5-fluorouracil. Oncol Rep 1997;4:685-690.
14. Nakane PK: Recent progress in the peroxidase-labeled antibody method. Ann NY Acad Sci 1975;254:203-211.
15. Spears CP, Shahinian AH, Moran RG, Heidelberger C, Corbett TH: In vivo kinetics of thymidylate synthase inhibition in 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res 1982;42:450-456.
16. Suzuki M, Sekiguchi I, Tamada T: Thymidylate synthase inhibition as a predictor of tumor sensitivity of fluorinated pyrimidines. Asia Oceania J Obstet Gynaecol 1990;16:175-180.